Cargando…

Metabolomics‐based identification of metabolic alterations in PARK2

OBJECTIVE: Parkin is the causative gene for autosomal recessive familial Parkinson's disease (PD), although it remains unclear how parkin dysfunction is involved with the general condition. Recently, serum and/or plasma metabolomics revealed alterations in metabolic pathways that might reflect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Okuzumi, Ayami, Hatano, Taku, Ueno, Shin‐Ichi, Ogawa, Takashi, Saiki, Shinji, Mori, Akio, Koinuma, Takahiro, Oji, Yutaka, Ishikawa, Kei‐Ichi, Fujimaki, Motoki, Sato, Shigeto, Ramamoorthy, Sivapriya, Mohney, Robert P., Hattori, Nobutaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414487/ https://www.ncbi.nlm.nih.gov/pubmed/30911576 http://dx.doi.org/10.1002/acn3.724

Ejemplares similares

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy
por: Mori, Akio, et al.
Publicado: (2019)

Nonmercaptalbumin as an oxidative stress marker in Parkinson’s and PARK2 disease
por: Ueno, Shin‐Ichi, et al.
Publicado: (2020)

Serum caffeine and metabolites are reliable biomarkers of early Parkinson disease
por: Fujimaki, Motoki, et al.
Publicado: (2018)

Decreased long-chain acylcarnitines from insufficient β-oxidation as potential early diagnostic markers for Parkinson’s disease
por: Saiki, Shinji, et al.
Publicado: (2017)

Shared Metabolic Profile of Caffeine in Parkinsonian Disorders
por: Takeshige‐Amano, Haruka, et al.
Publicado: (2020)

Diffusion MRI Captures White Matter Microstructure Alterations in PRKN Disease
por: Koinuma, Takahiro, et al.
Publicado: (2021)

Identifying Therapeutic Agents for Amelioration of Mitochondrial Clearance Disorder in Neurons of Familial Parkinson Disease
por: Yamaguchi, Akihiro, et al.
Publicado: (2020)

Zonisamide Administration Improves Fatty Acid β-Oxidation in Parkinson’s Disease
por: Ueno, Shin-Ichi, et al.
Publicado: (2018)

A metabolic profile of polyamines in parkinson disease: A promising biomarker
por: Saiki, Shinji, et al.
Publicado: (2019)

Metabolomic analysis data of MPP(+)-exposed SH-SY5Y cells using CE-TOFMS
por: Amo, Taku, et al.
Publicado: (2020)

Systemic Metabolic Alteration Dependent on the Thyroid‐Liver Axis in Early PD
por: Miyamoto, Kengo, et al.
Publicado: (2022)

Non-invasive diagnostic tool for Parkinson’s disease by sebum RNA profile with machine learning
por: Uehara, Yuya, et al.
Publicado: (2021)

A Retrospective Imaging Evaluation of Presynaptic Dopaminergic Degeneration in Multiple System Atrophy with Levodopa Induced Dyskinesia
por: Ueno, Shin-ichi, et al.
Publicado: (2020)

Multi-year whole-blood transcriptome data for the study of onset and progression of Parkinson’s Disease
por: Valentine, Matthew N. Z., et al.
Publicado: (2019)

Propagative α-synuclein seeds as serum biomarkers for synucleinopathies
por: Okuzumi, Ayami, et al.
Publicado: (2023)

Myalgia caused by chronic myositis associated with plasmacytosis: a case report
por: Hatano, Taku, et al.
Publicado: (2018)

Parkinson’s disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and α-synuclein stability through membrane remodeling
por: Mori, Akio, et al.
Publicado: (2019)

Acute psychosis as an initial manifestation of hypothyroidism: a case report
por: Ueno, Shinichi, et al.
Publicado: (2015)

Intrajejunal Infusion of Levodopa/Carbidopa for Advanced Parkinson's Disease: A Systematic Review
por: Tsunemi, Taiji, et al.
Publicado: (2021)

Rapid dissemination of alpha-synuclein seeds through neural circuits in an in-vivo prion-like seeding experiment
por: Okuzumi, Ayami, et al.
Publicado: (2018)

p150(glued)-Associated Disorders Are Caused by Activation of Intrinsic Apoptotic Pathway
por: Ishikawa, Kei-Ichi, et al.
Publicado: (2014)

Cerebrospinal fluid dissemination of anaplastic intraventricular meningioma: report of a case presenting with progressive brainstem dysfunction and multiple cranial nerve palsies
por: Fujimaki, Motoki, et al.
Publicado: (2016)

Identification of Licopyranocoumarin and Glycyrurol from Herbal Medicines as Neuroprotective Compounds for Parkinson's Disease
por: Fujimaki, Takahiro, et al.
Publicado: (2014)

Current Status of Telemedicine for Parkinson’s Disease in Japan: A Single-Center Cross-Sectional Questionnaire Survey
por: Ogawa, Mayuko, et al.
Publicado: (2022)

α‐Synuclein V15A Variant in Familial Parkinson's Disease Exhibits a Weaker Lipid‐Binding Property
por: Daida, Kensuke, et al.
Publicado: (2022)

Quantum-dot-labeled synuclein seed assay identifies drugs modulating the experimental prion-like transmission
por: Imamura, Yukio, et al.
Publicado: (2022)

The Risk Factors for the Wearing-off Phenomenon in Parkinson's Disease in Japan: A Cross-sectional, Multicenter Study
por: Ouma, Shinji, et al.
Publicado: (2017)

Analytical and clinical validity of wearable, multi-sensor technology for assessment of motor function in patients with Parkinson’s disease in Japan
por: Oyama, Genko, et al.
Publicado: (2023)

Graphic Summary of Movement Disorders Society Criteria for Progressive Supranuclear Palsy and Multiple Allocations eXtinction Rules
por: Ogawa, Takashi, et al.
Publicado: (2020)

Investigating the efficacy and safety of elobixibat, an ileal bile acid transporter inhibitor, in patients with Parkinson’s disease with chronic constipation: a multicentre, placebo-controlled, randomised, double-blind, parallel-group study (CONST-PD)
por: Hatano, Taku, et al.
Publicado: (2022)

A Case of Tardive Dystonia with Task Specificity Confined to the Lower Extremities only during Walking
por: Hatori, Kozo, et al.
Publicado: (2023)

Good’s syndrome with opportunistic infection of the central nervous system: a case report
por: Ueno, Shinichi, et al.
Publicado: (2015)

Motor/Nonmotor Symptoms and Progression in Patients with Parkinson's Disease: Prevalence and Risks in a Longitudinal Study
por: Yoritaka, Asako, et al.
Publicado: (2020)

Nonmotor Symptoms in Patients with PARK2 Mutations
por: Yoritaka, Asako, et al.
Publicado: (2011)

Neuromelanin or DaT‐SPECT: which is the better marker for discriminating advanced Parkinson's disease?
por: Okuzumi, A., et al.
Publicado: (2019)

Involvement of casein kinase 1 epsilon/delta (Csnk1e/d) in the pathogenesis of familial Parkinson's disease caused by CHCHD2
por: Torii, Satoru, et al.
Publicado: (2023)

Spontaneous spinal subarachnoid hemorrhage after severe coughing: a case report
por: Oji, Yutaka, et al.
Publicado: (2013)

Loss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice
por: Sato, Shigeto, et al.
Publicado: (2018)

Randomized double-blind placebo-controlled trial of hydrogen inhalation for Parkinson’s disease: a pilot study
por: Yoritaka, Asako, et al.
Publicado: (2021)

Reduced astrocytic reactivity in human brains and midbrain organoids with PRKN mutations
por: Kano, Masayoshi, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mde98sg3tl8rnv6mkeit2eh18t